Alerts will be sent to your verified email
Verify Email
IFL
|
IFL Enterprises
|
Mishka Exim
|
Biogen Pharmachem
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
3.21 % | 0.38 % | 0.19 % |
|
5yr average Equity Multiplier
|
1.18 | 1.12 | 1.01 |
|
5yr Average Asset Turnover Ratio
|
0.42 | 0.37 | 0.02 |
|
5yr Avg Net Profit Margin
|
7.56 % | 3.65 % | -19.83 % |
|
Price to Book
|
0.5 | 2.84 | 0.67 |
|
P/E
|
7.15 | 80.3 | 38.35 |
|
5yr Avg Cash Conversion Cycle
|
103.14 Days | 327.11 Days | 0.0 |
|
Inventory Days
|
25.92 Days | 248.34 Days | 0.0 |
|
Days Receivable
|
156.92 Days | 89.7 Days | 0.0 |
|
Days Payable
|
45.43 Days | 24.26 Days | 3.0 Days |
|
5yr Average Interest Coverage Ratio
|
313.41 | 25.41 | 902.8 |
|
5yr Avg ROCE
|
4.4 % | 0.25 % | 0.2 % |
|
5yr Avg Operating Profit Margin
|
-0.7 % | 2.99 % | -19.88 % |
|
5 yr average Debt to Equity
|
0.02 | 0.01 | 0.0 |
|
5yr CAGR Net Profit
|
40.82 % | 4.88 % | -28.94 % |
|
5yr Average Return on Assets
|
2.74 % | 0.33 % | 0.19 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 59.21 % | 0.0 |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-1.21 % | 6.34 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
IFL Enterprises
|
Mishka Exim
|
Biogen Pharmachem
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
-
|